Atlas Trials

Study to Assess the Effect of Gabapentin Enacarbil on Simulated Driving in Healthy Subjects

Clinical trial NCT01411124 · COMPLETED

Trial details

NCT number
NCT01411124
Sponsor
XenoPort, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Restless Legs Syndrome (RLS)
Start date
2011-06-01
Primary completion
2011-10-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.